Skip to main content


Revised Hyperbilirubinemia Guidelines

Schematic diagram demonstrating the production, metabolism, and excretion of bilirubin. UpToDate, 2022.

Revised Hyperbilirubinemia Guidelines

In September 2022, the American Academy of Pediatrics (AAP) issued revised clinical guidelines for preventing, treating, and monitoring hyperbilirubinemia in infants 35 weeks or greater. The revised guidelines incorporate new research findings on risk assessment and treatment.  

It is imperative that existing facility policies be updated and that nursing staff and providers follow the new guidelines. We aimed to have 100% of Nebraska birthing facilities implement these changes by June 30th, 2023. As of January 2024, 44 out of 45 birthing facilities have updated their hyperbilirubinemia policies. 

BiliTool and PediTools have been updated to reflect the 2022 recommendations. 



Project Resources

AAP Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation (2022)

Update Bilirubin Graphs (2022)

NPQIC Hyperbilirubinemia Webinar Handout (2/2023)

FAQs Sheet (5/2023)

Online Bilirubin Tools